185 related articles for article (PubMed ID: 3212779)
1. Inhibitory effect of CR-1409, a competitive inhibitor of cholecystokinin, on pancreatic exocrine secretion in the conscious rat.
Miyasaka K; Nakamura R; Funakoshi A; Kitani K
Tohoku J Exp Med; 1988 Jun; 155(2):165-72. PubMed ID: 3212779
[TBL] [Abstract][Full Text] [Related]
2. The effect of CR 1409, a potent CCK receptor antagonist, on basal and stimulated pancreatic secretion in rat.
Takács T; Nagy I; Pap A; Varró V
Pancreas; 1990; 5(1):60-4. PubMed ID: 2293712
[TBL] [Abstract][Full Text] [Related]
3. [Inhibitory effect of CR 1409 (cholecystokinin antagonist) on pancreatic exocrine secretion in rats].
Shiratori K; Watanabe S; Shimizu K; Moriyoshi Y; Chang JH; Takeuchi T
Nihon Shokakibyo Gakkai Zasshi; 1989 Jan; 86(1):70-6. PubMed ID: 2471850
[TBL] [Abstract][Full Text] [Related]
4. Biological effects of a proglumide derivative as cholecystokinin antagonist in conscious dogs.
Hildebrand P; Beglinger C; Köhler E; Setnikar I; Gyr K
Regul Pept; 1987 Aug; 18(3-4):213-20. PubMed ID: 3446223
[TBL] [Abstract][Full Text] [Related]
5. Effects of a new proglumide analogue CR 1392 on pancreatic exocrine secretion in the rat.
Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
Digestion; 1989; 42(2):61-9. PubMed ID: 2475379
[TBL] [Abstract][Full Text] [Related]
6. The anti-CCK effect of glutaramic acid derivatives in anesthetized and conscious rats.
Takács T; Nagy I; Pap A; Varró V
Pancreas; 1988; 3(4):465-70. PubMed ID: 3174609
[TBL] [Abstract][Full Text] [Related]
7. Proglumide analogues CR 1409 and CR 1392 inhibit cholecystokinin-stimulated insulin release more potently than exocrine secretion from the isolated perfused rat pancreas.
Okabayashi Y; Otsuki M; Nakamura T; Fujii M; Tani S; Fujisawa T; Koide M; Hasegawa H; Baba S
Pancreas; 1990 May; 5(3):291-7. PubMed ID: 2188254
[TBL] [Abstract][Full Text] [Related]
8. Hormonal mechanism of sodium oleate-stimulated pancreatic secretion in rats.
Li P; Lee KY; Chang TM; Chey WY
Am J Physiol; 1990 Dec; 259(6 Pt 1):G960-5. PubMed ID: 2260665
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of the cholecystokinin antagonist loxiglumide on pancreatic exocrine secretion and pancreatic growth in conscious rats.
Taguchi S; Green GM; Nakano I; Hatta Y
Int J Pancreatol; 1992 Apr; 11(2):67-73. PubMed ID: 1607730
[TBL] [Abstract][Full Text] [Related]
10. Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas.
Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
Dig Dis Sci; 1989 Jun; 34(6):857-64. PubMed ID: 2470557
[TBL] [Abstract][Full Text] [Related]
11. CR-1409: a potent inhibitor of cholecystokinin-stimulated amylase release and cholecystokinin binding in rat pancreatic acini.
Iwamoto Y; Yamamoto R; Kuzuya T
Pancreas; 1987; 2(1):85-90. PubMed ID: 2437574
[TBL] [Abstract][Full Text] [Related]
12. [Potentiating effect of secretin on cholecystokinin-stimulated exocrine pancreatic secretion in rats].
Moriyoshi Y
Nihon Shokakibyo Gakkai Zasshi; 1989 Oct; 86(10):2425-33. PubMed ID: 2480464
[TBL] [Abstract][Full Text] [Related]
13. Role of secretin and cholecystokinin in oleic acid-stimulated pancreatic secretion in rats.
Shiratori K; Watanabe S; Takeuchi T; Shimizu K; Moriyoshi Y
Gastroenterol Jpn; 1990 Feb; 25(1):104-11. PubMed ID: 1689684
[TBL] [Abstract][Full Text] [Related]
14. Bioactivity of synthetic human cholecystokinin (CCK)-33 in vitro and in vivo.
Shinozaki H; Miyasaka K; Wakasugi H; Fujii N; Funakoshi A
Gastroenterol Jpn; 1991 Feb; 26(1):51-5. PubMed ID: 1706670
[TBL] [Abstract][Full Text] [Related]
15. Cholecystokinin in the regulation of intestinal motility and pancreatic secretion in dogs.
Thor P; Laskiewicz J; Konturek P; Konturek SJ
Am J Physiol; 1988 Oct; 255(4 Pt 1):G498-504. PubMed ID: 3177646
[TBL] [Abstract][Full Text] [Related]
16. Effect of CCK antagonists CR 1409 and CR 1505 on rat pancreatic exocrine secretion in vivo.
Shiratori K; Shimizu K; Watanabe S; Takeuchi T; Moriyoshi Y
Pancreas; 1989; 4(6):744-50. PubMed ID: 2813333
[TBL] [Abstract][Full Text] [Related]
17. Interactions between bile and pancreatic juice diversions on cholecystokinin release and pancreas in conscious rats.
Nakamura R; Miyasaka K; Funakoshi A; Kitani K
Proc Soc Exp Biol Med; 1989 Nov; 192(2):182-6. PubMed ID: 2813449
[TBL] [Abstract][Full Text] [Related]
18. Necessity of hyperglycemia for effects of endogenous cholecystokinin on insulin and pancreatic exocrine secretion in conscious rats.
Shikado F; Miyasaka K; Funakoshi A; Kitani K
Jpn J Physiol; 1990; 40(3):383-91. PubMed ID: 2273636
[TBL] [Abstract][Full Text] [Related]
19. Effect of proglumide on rat pancreatic growth.
Yamaguchi T; Tabata K; Johnson LR
Am J Physiol; 1985 Aug; 249(2 Pt 1):G294-8. PubMed ID: 2411150
[TBL] [Abstract][Full Text] [Related]
20. [Inhibitory effect of a new proglumide derivative, loxiglumide, on CCK action in isolated rat pancreatic acini].
Fujii M; Otsuki M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
Nihon Shokakibyo Gakkai Zasshi; 1989 Jan; 86(1):77-82. PubMed ID: 2471851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]